TK-112690

DRUG3 trials

Sponsors

Tosk, Inc.

Conditions

Mucositis

Phase 2

Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690

CompletedNCT04046250

Tosk, Inc.Mucositis

Start: 2019-05-15End: 2020-03-31Updated: 2023-08-25

Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690

Tosk, Inc.Mucositis

Start: 2022-06-17End: 2023-09-30Target: 24Updated: 2023-08-14

Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690

Tosk, Inc.Mucositis

Start: 2022-06-15End: 2023-09-30Target: 24Updated: 2023-08-14